Foundation Medicine Inc Stock

Stocks

21/10/18	Bayer : Roche takes on Loxo, Bayer in gene-defined cancer class	RE
19/06/18	Citigroup : Roche pays $2.4 billion for rest of cancer expert Foundation Medicine	RE
04/12/17	Foundation Medicine : Roche's Foundation Medicine wins FDA blessing for new cancer test	RE
13/01/15	Alcoa : Wall St. falls; energy shares dragged down further by oil	RE
12/01/15	Foundation Medicine : Roche in $1 billion-plus Foundation Medicine deal to boost cancer efforts	RE

07/08/18	Foundation Medicine : Setting the Pace for Blood Tumor Mutational Burden	PU
06/08/18	Foundation Medicine : Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predictor of Response to Cancer Immunotherapy	BU
19/07/18	Foundation Medicine : and Guardant Health Agree to Settle Patent Infringement Lawsuit	BU
03/07/18	Beyond MSI: Expanding the Reach of Immunotherapy in Colorectal Cancer	PU
20/06/18	FOUNDATION MEDICINE, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU

19/06/18	Les valeurs à suivre aujourd'hui à Wall Street Mardi 19 juin 2018
19/06/18	Dow Jones Industrial Average : Les valeurs à suivre à Wall Street
19/06/18	FOUNDATION MEDICINE : racheté par ROCHE
19/06/18	USA-Les valeurs à suivre à Wall Street (actualisé)
19/06/18	Foundation Medicine : Roche will US-Gentest-Firma FMI ganz schlucken

Manager	Title	Age	Since
Vera Grossmann CEO	Chief Executive Officer	-	01/08/2026
Dominique Schutz DFI	Director of Finance/CFO	-	01/01/2022
Michael Kling CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Evan Jones BRD	Director/Board Member	69	08/01/2013

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FOUNDATION MEDICINE INC	-.--%	-.--%	-	-	0
WUXI APPTEC CO., LTD.	-2.69%	-0.48%	+53.97%	+70.99%	66.33B
ARGENX SE	-0.92%	+7.67%	+12.64%	+92.55%	60.62B
LONZA GROUP AG	0.00%	+0.39%	+22.34%	+90.83%	55.5B
BEONE MEDICINES AG	+0.14%	+2.35%	+13.86%	+106.64%	47.58B
IQVIA HOLDINGS INC.	-2.21%	-2.47%	+20.18%	+32.24%	43.69B
REVOLUTION MEDICINES, INC.	-2.30%	-10.40%	+154.30%	+725.54%	37.27B
CELLTRION, INC.	+2.15%	+1.42%	+14.58%	+54.23%	36.57B
GENMAB A/S	-2.32%	-2.24%	+76.50%	+54.55%	32.22B
INSMED INCORPORATED	+2.62%	+5.90%	-37.29%	+393.72%	26.58B
Average	-0.55%	+0.05%	+36.79%	+180.14%	45B
Weighted average by Cap.	-0.83%	+0.20%	+36.63%	+155.25%